Project Grant R01HL178992
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to extend an ongoing dietary weight loss intervention study and examine the impact of different weight loss approaches on long-term outcomes. The $468,000 award to the University of Colorado-Denver will: Compare post-intervention adherence and clinical outcomes (weight, body composition, cardiometabolic health) between the standard daily caloric restriction...
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded $2,350,623 under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Minnesota on May 1, 2021 for a project concluding on April 30, 2022. The project aims to reduce childhood obesity through an individual randomized controlled trial testing combinations of ecological momentary intervention, home visiting, and video feedback delivered to 510 low-income, racially...
- The federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $226,778 to Colorado State University from August 1, 2025 to July 31, 2028 to deliver a "Digitally Enhanced Cognitive-Behavioral Therapy for Adolescents with Depression and Obesity" research project. The project aims to investigate the effectiveness of a 6-week cognitive-behavioral therapy (CBT) group intervention, enhanced with digital...
- This Project Grant award, totaling $169,444, was provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to develop and pilot test a stress management intervention for Black adults with hypertension. The project will work with patients receiving care from federally-qualified health centers to iteratively design an intervention that addresses patient preferences and aims to promote cardiovascular health. Key outcomes to be examined include...
- This $3,690,570 Project Grant award from the National Institute of Nursing Research (NINR), under the Nursing Research federal grant program (CFDA 93.361), aims to improve obesity treatment among adults with food insecurity. The study will conduct a randomized controlled trial with 300 participants assigned to one of three groups: Behavioral Weight Loss (BWL) alone, BWL with food vouchers, or BWL with home-delivered, medically tailored groceries. The primary objective is to assess whether the...
- This $161,871 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) from August 2025 to July 2030, will fund a pilot study to refine and optimize a school-based obesity prevention intervention for adolescent girls in an urban informal settlement in Kenya. The key objectives are to: 1) Engage the community to refine intervention components based on previous research, and 2) Conduct a pilot Multiphase Optimization Strategy (MOST)...
- This federal Project Grant award for $170,601, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports the development and pilot testing of a multi-component remote care intervention for rural patients living with heart failure. The project aims to: 1) elicit feedback on remote intervention strategies to inform implementation of heart failure care within rural communities; 2) conduct a pilot trial to examine the feasibility and...
- The National Heart Lung and Blood Institute has awarded a $841,555 Cooperative Agreement under the Cardiovascular Diseases Research program (CFDA 93.837) to Harvard Pilgrim Health Care Inc. The "ENHANCE" project aims to integrate a nutrition enhancement within established, evidence-based, federally funded home visiting programs to promote healthier eating patterns and food access for families from lower incomes and underserved communities. The multi-level intervention will be...
- This Project Grant award from the U.S. Department of Health and Human Services' National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $1,072,621 to Duke University to conduct an adequately powered randomized controlled trial of a multi-component lifestyle intervention aimed at improving blood pressure control and cardiovascular outcomes in Black adults with chronic kidney disease (CKD). The goal is to evaluate the impact of lifestyle modifications,...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $766,277 to the University of North Carolina at Chapel Hill to optimize dietary adherence in a mobile behavioral weight loss intervention for adults. The project aims to use an innovative factorial trial design to identify intervention components that can directly improve dietary adherence for participants who do not initially respond well to the standard mobile-delivered behavioral weight loss program. This 5-year project seeks to address the challenge of poor dietary adherence in digital weight loss interventions, which can limit weight loss outcomes, in order to inform precision intervention approaches for adult obesity treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $766.3k | 9/8/25 |